Tuya Inc. (TUYA) Spending and interest coverage
- R&D / revenue · 12 months: Value 27.87%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value 6.92%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 27.87% | Research and development expense / revenue. Period ending 2025-12-31. $89.69M ÷ $321.79M × 100 ≈ 27.87% |
| Stock-based compensation / revenue · 12 months | 6.92% | Share-based compensation / revenue. Period ending 2025-12-31. $22.26M ÷ $321.79M × 100 ≈ 6.92% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 89.69M USD | Research and Development Expense |
| Revenue | 321.79M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 22.26M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 11.48M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $89.69M | $321.79M | $22.26M | $11.48M | (m) | 27.87% | 6.92% | (m) | (m) |
| 2024-12-31 | $95.05M | $298.62M | $67.75M | $-47.62M | (m) | 31.83% | 22.69% | (m) | (m) |
| 2023-12-31 | $102.28M | $229.99M | $65.22M | $-105.82M | (m) | 44.47% | 28.36% | (m) | (m) |
| 2022-12-31 | $144.94M | $208.17M | $69.02M | $-168.19M | (m) | 69.63% | 33.15% | (m) | (m) |
| 2021-12-31 | $174.29M | $302.08M | $66.09M | $-183.56M | (m) | 57.70% | 21.88% | (m) | (m) |
| 2020-12-31 | $77.43M | $179.87M | $9.45M | $-69.85M | (m) | 43.05% | 5.25% | (m) | (m) |
| 2019-12-31 | $52.00M | $105.79M | $5.22M | $-73.44M | (m) | 49.16% | 4.93% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.